FOR THE END OF
THE WEEK IN A FEW MINUTES.
ADAM: THANK YOU.
TURNING TO NEW HAMPSHIRE'S DRUG
CRISIS, TODAY NEW PRESCRIBING
REGULATIONS TAKE EFFECT AIMED AT
REDUCING THE NUMBER OF OPIOID
PILLS USED IN NEW HAMPSHIRE.
WE SPOKE TO THE CHIEF MEDICAL
OFFICER AT CMC IN MANCHESTER WHO
SAYS THE NEW RULES WILL HELP BUT
COULD EXPOSE ANOTHER PROBLEM.
FOR YEARS NOW, NEW HAMPSHIRE HAS
BEEN AWASH IN PRESCRIPTION
OPIOID PILLS.
>> WE KNOW THAT THIS CRISIS
WE'RE IN NOW WITH THE OPIOID
EPIDEMIC, WITH PEOPLE SUFFERING
ADDICTION AND OVERDOSES AND SO
ON, WE KNOW THAT LOOKING BACK
THE NUMBER OF PRESCRIPTIONS HAS
QUADRUPLED SINCE ABOUT THE YEAR
2000.
ADAM: NEW REGULATIONS AROUND
PRESCRIBING TAKE EFFECT TODAY,
AIMED AT CURBING THAT END OF THE
OPIOID ABUSE PROBLEM.
BEFORE WRITING A PRESCRIPTION,
MEDICAL PROFESSIONALS MUST
CONDUCT A PATIENT RISK
ASSESSMENT.
THE PATIENT MUST SIGN AN
INFORMED CONSENT FORM.
AND THEN THE REQUEST FOR OPIOIDS
WILL BE CHECKED AGAINST THE
DATABASE IN THE PRESCRIPTION
DRUG MONITORING PROGRAM, TO
ENSURE THE PATIENT ISN'T SEEKING
DRUGS FROM MULTIPLE DOCTORS.
THE DESIRED END RESULT IS
SIMPLE.
>> BY PUTTING FEWER PILLS OUT ON
THE STREET, THERE'S LESS CHANCE
FOR DIVERSION AND MISUSE.
ADAM: DR. WILLIAM GOODMAN, THE
CHIEF MEDICAL OFFICER AT CMC,
SAYS WHILE THE NEW RULES SHOULD
HELP, THEY WILL ALSO EXPOSE
ANOTHER PROBLEM WITH
PRESCRIPTION PAINKILLERS.
>> WHICH IS THAT SOME OF THE
SAFER AND VERY EFFECTIVE
ALTERNATIVES ARE OFTEN DIFFICULT
TO AFFORD, EITHER BECAUSE
THEY'RE TOO EXPENSIVE OR HEALTH
INSURANCE COMPANIES DON'T
SUPPORT THEIR USE.
ADAM: DR. GOODMAN SAYS THAT WILL
NEED TO BE ADDRESSED, BUT THE
EXPECTATION IS THAT 2017 WILL
MARK PROGRESS ON THE PRESCRIBING
FRONT OF THE OPIOID CRISIS.
>> WHAT'S BEING DONE HERE HAS
BEEN SHOWN TO BE EFFECTIVE
ELSEWHERE, AND WE HOPEFULLY WILL
HAVE THE SAME SUCCESS IN SEEING
LESS PILLS ON THE STREET AND
LESS PEOPLE SUFFERING FROM THE
SIDE EFFECTS OF OPIOIDS.
ADAM: DR. GOODMAN SAYS IT'S
IMPORTANT TO NOTE THAT PATIENTS
WHO TRULY NEED OPIOID
PAINKILLERS WILL STILL BE ABLE
TO GET THEM, ALTHOUGH THE COURSE
Không có nhận xét nào:
Đăng nhận xét